Inmune Bio, Inc.

Nasdaq INMB · Boca Raton, FL

Works in Hematology · Infectious disease · Neurology · Psychiatry · Respiratory

Inmune Bio, Inc. is a clinical trial sponsor based in Boca Raton, FL, listed as Nasdaq INMB. It has no active clinical trials as lead sponsor; its trials since 2021 were across 5 therapeutic areas. Since 2021 it has completed 3 trials and stopped 4 early.

Trial track record · since 2021

0Active trials0 planned participants
3Completed2 with results posted
4Stopped early57% of finished trials

Financials · Nasdaq INMB

Cash and equivalents
R&D expense
Net income (loss)
Cash runway

Fundraising

Pipeline · 0 active trials

No active trials with this company as lead sponsor.

Questions about Inmune Bio, Inc

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-06-29.

Approve Suite is not affiliated with Inmune Bio, Inc..

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.